Comparative economic evaluation of home-based and hospital-based palliative care for terminal cancer patients

Koki Kato, Haruhisa Fukuda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim: To quantify the difference between adjusted costs for home-based palliative care and hospital-based palliative care in terminally ill cancer patients. Methods: We carried out a case–control study of home-care patients (cases) who had died at home between January 2009 and December 2013, and hospital-care patients (controls) who had died at a hospital between April 2008 and December 2013. Data on patient characteristics were obtained from insurance claims data and medical records. We identified the determinants of home care using a multivariate logistic regression analysis. Cox proportional hazards analysis was used to examine treatment duration in both types of care, and a generalized linear model was used to estimate the reduction in treatment costs associated with home care. Results: The case and control groups comprised 48 and 99 patients, respectively. Home care was associated with one or more person(s) living with the patient (adjusted OR 6.54, 95% CI 1.18–36.05), required assistance for activities of daily living (adjusted OR 3.61, 95% CI 1.12–10.51), non-use of oxygen inhalation therapy (adjusted OR 12.75, 95% CI 3.53–46.02), oral or suppository opioid use (adjusted OR 5.74, 95% CI 1.11–29.54) and transdermal patch opioid use (adjusted OR 8.30, 95% CI 1.97–34.93). The adjusted hazard ratio of home care for treatment duration was not significant (adjusted OR 0.95, 95% CI 0.59–1.53). However, home care was significantly associated with a reduction of $7523 (95% CI $7093–7991, P = 0.015) in treatment costs. Conclusions: Despite similar treatment durations between the groups, treatment costs were substantially lower in the home-care group. These findings might inform the policymaking process for improving the home-care support system. Geriatr Gerontol Int 2017; 17: 2247–2254.

Original languageEnglish
Pages (from-to)2247-2254
Number of pages8
JournalGeriatrics and Gerontology International
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 1 2017

Fingerprint

Home Care Services
home care
Palliative Care
Cost-Benefit Analysis
cancer
evaluation
economics
Neoplasms
Health Care Costs
costs
Opioid Analgesics
Oxygen Inhalation Therapy
insurance claim
Transdermal Patch
Terminally Ill
Suppositories
Group
Activities of Daily Living
linear model
Insurance

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Gerontology
  • Geriatrics and Gerontology

Cite this

Comparative economic evaluation of home-based and hospital-based palliative care for terminal cancer patients. / Kato, Koki; Fukuda, Haruhisa.

In: Geriatrics and Gerontology International, Vol. 17, No. 11, 01.11.2017, p. 2247-2254.

Research output: Contribution to journalArticle

@article{004d0ca9277f41ec817be532ca4d6d7c,
title = "Comparative economic evaluation of home-based and hospital-based palliative care for terminal cancer patients",
abstract = "Aim: To quantify the difference between adjusted costs for home-based palliative care and hospital-based palliative care in terminally ill cancer patients. Methods: We carried out a case–control study of home-care patients (cases) who had died at home between January 2009 and December 2013, and hospital-care patients (controls) who had died at a hospital between April 2008 and December 2013. Data on patient characteristics were obtained from insurance claims data and medical records. We identified the determinants of home care using a multivariate logistic regression analysis. Cox proportional hazards analysis was used to examine treatment duration in both types of care, and a generalized linear model was used to estimate the reduction in treatment costs associated with home care. Results: The case and control groups comprised 48 and 99 patients, respectively. Home care was associated with one or more person(s) living with the patient (adjusted OR 6.54, 95{\%} CI 1.18–36.05), required assistance for activities of daily living (adjusted OR 3.61, 95{\%} CI 1.12–10.51), non-use of oxygen inhalation therapy (adjusted OR 12.75, 95{\%} CI 3.53–46.02), oral or suppository opioid use (adjusted OR 5.74, 95{\%} CI 1.11–29.54) and transdermal patch opioid use (adjusted OR 8.30, 95{\%} CI 1.97–34.93). The adjusted hazard ratio of home care for treatment duration was not significant (adjusted OR 0.95, 95{\%} CI 0.59–1.53). However, home care was significantly associated with a reduction of $7523 (95{\%} CI $7093–7991, P = 0.015) in treatment costs. Conclusions: Despite similar treatment durations between the groups, treatment costs were substantially lower in the home-care group. These findings might inform the policymaking process for improving the home-care support system. Geriatr Gerontol Int 2017; 17: 2247–2254.",
author = "Koki Kato and Haruhisa Fukuda",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/ggi.12977",
language = "English",
volume = "17",
pages = "2247--2254",
journal = "Geriatrics and Gerontology International",
issn = "1447-0594",
publisher = "Japan Geriatrics Society",
number = "11",

}

TY - JOUR

T1 - Comparative economic evaluation of home-based and hospital-based palliative care for terminal cancer patients

AU - Kato, Koki

AU - Fukuda, Haruhisa

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Aim: To quantify the difference between adjusted costs for home-based palliative care and hospital-based palliative care in terminally ill cancer patients. Methods: We carried out a case–control study of home-care patients (cases) who had died at home between January 2009 and December 2013, and hospital-care patients (controls) who had died at a hospital between April 2008 and December 2013. Data on patient characteristics were obtained from insurance claims data and medical records. We identified the determinants of home care using a multivariate logistic regression analysis. Cox proportional hazards analysis was used to examine treatment duration in both types of care, and a generalized linear model was used to estimate the reduction in treatment costs associated with home care. Results: The case and control groups comprised 48 and 99 patients, respectively. Home care was associated with one or more person(s) living with the patient (adjusted OR 6.54, 95% CI 1.18–36.05), required assistance for activities of daily living (adjusted OR 3.61, 95% CI 1.12–10.51), non-use of oxygen inhalation therapy (adjusted OR 12.75, 95% CI 3.53–46.02), oral or suppository opioid use (adjusted OR 5.74, 95% CI 1.11–29.54) and transdermal patch opioid use (adjusted OR 8.30, 95% CI 1.97–34.93). The adjusted hazard ratio of home care for treatment duration was not significant (adjusted OR 0.95, 95% CI 0.59–1.53). However, home care was significantly associated with a reduction of $7523 (95% CI $7093–7991, P = 0.015) in treatment costs. Conclusions: Despite similar treatment durations between the groups, treatment costs were substantially lower in the home-care group. These findings might inform the policymaking process for improving the home-care support system. Geriatr Gerontol Int 2017; 17: 2247–2254.

AB - Aim: To quantify the difference between adjusted costs for home-based palliative care and hospital-based palliative care in terminally ill cancer patients. Methods: We carried out a case–control study of home-care patients (cases) who had died at home between January 2009 and December 2013, and hospital-care patients (controls) who had died at a hospital between April 2008 and December 2013. Data on patient characteristics were obtained from insurance claims data and medical records. We identified the determinants of home care using a multivariate logistic regression analysis. Cox proportional hazards analysis was used to examine treatment duration in both types of care, and a generalized linear model was used to estimate the reduction in treatment costs associated with home care. Results: The case and control groups comprised 48 and 99 patients, respectively. Home care was associated with one or more person(s) living with the patient (adjusted OR 6.54, 95% CI 1.18–36.05), required assistance for activities of daily living (adjusted OR 3.61, 95% CI 1.12–10.51), non-use of oxygen inhalation therapy (adjusted OR 12.75, 95% CI 3.53–46.02), oral or suppository opioid use (adjusted OR 5.74, 95% CI 1.11–29.54) and transdermal patch opioid use (adjusted OR 8.30, 95% CI 1.97–34.93). The adjusted hazard ratio of home care for treatment duration was not significant (adjusted OR 0.95, 95% CI 0.59–1.53). However, home care was significantly associated with a reduction of $7523 (95% CI $7093–7991, P = 0.015) in treatment costs. Conclusions: Despite similar treatment durations between the groups, treatment costs were substantially lower in the home-care group. These findings might inform the policymaking process for improving the home-care support system. Geriatr Gerontol Int 2017; 17: 2247–2254.

UR - http://www.scopus.com/inward/record.url?scp=85012936608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012936608&partnerID=8YFLogxK

U2 - 10.1111/ggi.12977

DO - 10.1111/ggi.12977

M3 - Article

C2 - 28181371

AN - SCOPUS:85012936608

VL - 17

SP - 2247

EP - 2254

JO - Geriatrics and Gerontology International

JF - Geriatrics and Gerontology International

SN - 1447-0594

IS - 11

ER -